As of Oct 02
| +2.26 / +5.02%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 76.00, with a high estimate of 76.00 and a low estimate of 76.00. The median estimate represents a +60.85% increase from the last price of 47.25.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.